These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37343143)

  • 41. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
    Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
    Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of the MEDIA echo score for the prognosis of heart failure with preserved ejection fraction.
    Coiro S; Huttin O; Kobayashi M; Lamiral Z; Simonovic D; Zannad F; Rossignol P; Girerd N
    Heart Fail Rev; 2023 Mar; 28(2):453-464. PubMed ID: 36038694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient-reported outcomes in heart failure with preserved vs. reduced ejection fraction: focus on physical independence.
    Huang W; Teng TK; Tay WT; Richards AM; Kadam U; Lawson CA; Shimizu W; Loh SY; Anand I; Lam CSP
    ESC Heart Fail; 2020 Oct; 7(5):2051-2062. PubMed ID: 32862518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
    Zhang X; Lv X; Wang N; Yu S; Si J; Zhang Y; Cai M; Liu Y
    Int J Cardiol; 2023 Aug; 385():34-40. PubMed ID: 37257517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal tubular damage and clinical outcome in heart failure with preserved ejection fraction and chronic kidney disease.
    Otaki Y; Watanabe T; Shimizu M; Tachibana S; Sato J; Kobayashi Y; Saito Y; Aono T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Watanabe M
    ESC Heart Fail; 2023 Aug; 10(4):2458-2468. PubMed ID: 37264723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Usefulness of B-Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction.
    Liu X; Abudukeremu A; Yu P; Cao Z; Sun R; Wu M; Chen Z; Ma J; Zhu W; Chen Y; Zhang Y; Wang J
    J Am Heart Assoc; 2022 Aug; 11(15):e024302. PubMed ID: 35904188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.
    Lin TK; Hsu BC; Li YD; Chen CH; Lin JW; Chien CY; Weng CY
    J Am Heart Assoc; 2019 Jun; 8(12):e010739. PubMed ID: 31181979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection Fraction.
    Choi KH; Yang JH; Seo JH; Hong D; Youn T; Joh HS; Lee SH; Kim D; Park TK; Lee JM; Song YB; Choi JO; Hahn JY; Choi SH; Gwon HC; Jeon ES
    J Am Heart Assoc; 2023 Mar; 12(6):e027581. PubMed ID: 36892042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.
    Koller L; Kleber M; Goliasch G; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer T; Delgado G; Tomaschitz A; Pilz S; März W; Niessner A
    Eur J Heart Fail; 2014 Jul; 16(7):758-66. PubMed ID: 24806206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heart failure with preserved ejection fraction after left-sided valve surgery: prevalent and relevant.
    Kammerlander AA; Nitsche C; Donà C; Koschutnik M; Dannenberg V; Mascherbauer K; Schönbauer R; Zafar A; Winter MP; Bartko PE; Goliasch G; Hengstenberg C; Mascherbauer J
    Eur J Heart Fail; 2021 Dec; 23(12):2008-2016. PubMed ID: 34506046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health Status Predicts Short- and Long-Term Risk of Composite Clinical Outcomes in Acute Heart Failure.
    Hu D; Liu J; Zhang L; Bai X; Tian A; Huang X; Zhou K; Gao M; Ji R; Miao F; Li J; Li W; Ge J; He G; Li J
    JACC Heart Fail; 2021 Dec; 9(12):861-873. PubMed ID: 34509406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutrophil-to-lymphocyte ratio and outcomes in patients with new-onset or worsening heart failure with reduced and preserved ejection fraction.
    Curran FM; Bhalraam U; Mohan M; Singh JS; Anker SD; Dickstein K; Doney AS; Filippatos G; George J; Metra M; Ng LL; Palmer CN; Samani NJ; van Veldhuisen DJ; Voors AA; Lang CC; Mordi IR
    ESC Heart Fail; 2021 Aug; 8(4):3168-3179. PubMed ID: 33998162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 59. A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
    Davies DR; Redfield MM; Scott CG; Minamisawa M; Grogan M; Dispenzieri A; Chareonthaitawee P; Shah AM; Shah SJ; Wehbe RM; Solomon SD; Reddy YNV; Borlaug BA; AbouEzzeddine OF
    JAMA Cardiol; 2022 Oct; 7(10):1036-1044. PubMed ID: 36069809
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.
    Park JJ; Cho YJ; Oh IY; Park HA; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    Int J Cardiol; 2017 Dec; 248():239-245. PubMed ID: 28821416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.